company background image
BLAU3 logo

Blau Farmacêutica BOVESPA:BLAU3 Stock Report

Last Price

R$12.22

Market Cap

R$2.2b

7D

1.7%

1Y

-50.5%

Updated

28 Mar, 2024

Data

Company Financials +

Blau Farmacêutica S.A.

BOVESPA:BLAU3 Stock Report

Market Cap: R$2.2b

BLAU3 Stock Overview

Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay.

BLAU3 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Blau Farmacêutica S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Blau Farmacêutica
Historical stock prices
Current Share PriceR$12.22
52 Week HighR$25.40
52 Week LowR$11.53
Beta0.36
1 Month Change-2.78%
3 Month Change-25.53%
1 Year Change-50.49%
3 Year Changen/a
5 Year Changen/a
Change since IPO-70.27%

Recent News & Updates

Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

Feb 01
Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

Recent updates

Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

Feb 01
Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

May 14
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Feb 24
Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Oct 14
Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Aug 17
Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Shareholder Returns

BLAU3BR BiotechsBR Market
7D1.7%0.4%-0.5%
1Y-50.5%3.3%17.7%

Return vs Industry: BLAU3 underperformed the BR Biotechs industry which returned 2.8% over the past year.

Return vs Market: BLAU3 underperformed the BR Market which returned 18.9% over the past year.

Price Volatility

Is BLAU3's price volatile compared to industry and market?
BLAU3 volatility
BLAU3 Average Weekly Movement5.0%
Biotechs Industry Average Movement9.1%
Market Average Movement4.7%
10% most volatile stocks in BR Market8.1%
10% least volatile stocks in BR Market2.2%

Stable Share Price: BLAU3's share price has been volatile over the past 3 months.

Volatility Over Time: BLAU3's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19871,900Marcelo Hahnhttps://www.blau.com

Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. The company’s medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets.

Blau Farmacêutica S.A. Fundamentals Summary

How do Blau Farmacêutica's earnings and revenue compare to its market cap?
BLAU3 fundamental statistics
Market capR$2.16b
Earnings (TTM)R$249.81m
Revenue (TTM)R$1.37b

8.7x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BLAU3 income statement (TTM)
RevenueR$1.37b
Cost of RevenueR$882.38m
Gross ProfitR$490.25m
Other ExpensesR$240.44m
EarningsR$249.81m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 07, 2024

Earnings per share (EPS)1.41
Gross Margin35.72%
Net Profit Margin18.20%
Debt/Equity Ratio28.6%

How did BLAU3 perform over the long term?

See historical performance and comparison

Dividends

6.1%

Current Dividend Yield

10%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.